Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells

Oncology Research

Volumn 16, Issue 2, 2006, Pages 75-84

  Wu, Wei ^a   Chen, Yen Hao ^a   Ueda, Eric ^a,b   Tan, Dunyong ^a   Bartolini, Paolo ^b   Walker, Ameae M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1,25 Dihydroxy vitamin D 3; Cell cycle regulatory proteins; Cyclin D; Cyclin dependent kinases 2 and 4; MAP kinase; p21; Phosphorylated prolactin; Prolactin; Vitamin D receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; GAG PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHORYLATED PROLACTIN; PROLACTIN; PROLACTIN DERIVATIVE; PROTEIN P21; REGULATOR PROTEIN; UNCLASSIFIED DRUG; UNMODIFIED PROLACTIN; VITAMIN D RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 33745699690     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981233     Document Type: Article

References (43)

1. Oetting, W. S.; Tuazon, P. T.; Traugh, J. A.; Walker, A. M. Phosphorylation of prolactin. J. Biol. Chem. 261: 1649-1652; 1986.
2. Ho, T. W. C.; Kawaminami, M.; Walker, A. M. Secretion of phosphorylated and nonphosphorylated monomer prolactin isoforms during rat pregnancy and pseudopregnancy. Endocr. J. 1:435-439; 1993.
3. Ho, T. W. C.; Leong, F. S.; Olaso, C. H.; Walker, A. M. Secretion of specific non-phosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle. Neuroendocrinolology 58:160-165; 1993.
4. Krown, K. A.; Wang, Y.-F.; Ho, T. W. C.; Kelly, P. A.; Walker, A. M. Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology 131:595-602; 1992.
5. Wang, Y.-F.; Walker, A. M. Dephosphorylation of standard prolactin produces a more biologically active molecule: Evidence for antagonism between non-phosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 133:2146-2160; 1993.
6. Wang, Y.-F.; Liu, J. W.; Mamidi, M.; Walker, A. M. Identification of the major site of rat prolactin phosphorylation as serine 177. J. Biol. Chem. 271:2462-2469; 1996.
7. Tuazon, P. T.; Lorenson, M. Y.; Walker, A. M.; Traugh, J. A. p21-Activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin. FEBS Lett. 515:84-88; 2002.
8. Chen, T. J.; Kuo, C. B.; Tsai, K. F.; Liu, J. W.; Chen, D. Y.; Walker, A. M. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 139:609-616; 1998.
9. Yang, L.; Kuo, C. B.; Liu, Y.; Coss, D.; Xu, X.; Chen, C.; Oster-Granite, M.-L.; Walker, A. M. Administration of unmodified prolactin (U-PRL) and a molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissues. J. Endocrinol. 168:227-238; 2001.
10. Yang, L.; Lii, S.; Kuo, B.; Buckley, A.; Buckley, D.; Chen, C.; Xu, X.; Coss, D.; Walker, A. M. Maternal prolactin composition can permanently affect epidermal γδ T cell function in the offspring. Dev. Comp. Immunol. 26: 849-860; 2002.
11. Kuo, C. B.; Wu, W.; Xu, W.; Yang, L.; Chen, C.; Coss, D.; Birdsall, B.; Nasseri, D.; Walker, A. M. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes β-casein gene expression in the rat mammary gland. Cell Tissue Res. 309:429-437; 2002.
12. Xu, X.; Kreye, E.; Kuo, C. B.; Walker, A. M. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res. 61:6098-6114; 2001.
13. Xu, X.; Wu, W.; Williams, V.; Khong, A.; Chen, Y. H.; Deng, C.; Walker, A. M. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. Prostate 54:25-33; 2003.
14. Krishnan, N.; Thellin, O.; Buckley, D.; Horseman, N. D.; Buckley, A. R. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 144: 2102-2110; 2003.
15. Witorsch, R. J.; Day, E. B.; Lavoie, H. A.; Hashim, N.; Taylor, J. K. Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proc. Soc. Exp. Biol. Med. 203:454-460; 1993.
16. Naylor, M. J.; Oakes, S. R.; Gardiner-Garden, M.; Harris, J.; Blazek, K.; Ho, T. W. C.; Li, F. C.; Wynick, D.; Walker, A. M.; Ormandy, C. J. Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol. Endocrinol. 19:1868-1883; 2005.
17. Taverna, D.; Groner, B.; Hynes, N. Epidermal growth factor receptor, platelet-derived growth factor receptor and c-erb-b-2 receptor activation all promote growth, but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ. 2:145-154; 1991.
18. Schroeder, M. D.; Symowicz, J.; Schuler, L. A. PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol. Endocrinol. 16:45-57; 2001.
19. Brockman, J. L.; Schroeder, M. D.; Schuler, L. A. PRL activates the cyclin D1 promoter via Jak2/Stat pathway. Mol. Endocrinol. 16:774-784; 2002.
20. Eisman, J. A.; Martin, T. J.; MacIntyre, I.; Moseley, J. M. 1,25-dihydroxyvitamin D receptor in breast cancer cells. Lancet 2:1335-1336; 1979.
21. Brooks, C. L.; Kim, B. G.; Aphale, P.; Kleeman, B. E.; Johnson, G. C. Phosphorylated variant of bovine prolactin. Mol. Cell. Endocrinol. 71:117-123; 1990.
22. Aramburo, C.; Montiel, J. L.; Proudman, J. A.; Berghman, L. R.; Scanes, C. G. Phosphorylation of prolactin and growth hormone. J. Mol. Endocrinol. 8:183-191; 1992.
23. Wu, W.; Coss, D.; Lorenson, M. Y.; Kuo, C. B.; Xu, X.; Walker, A. M. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 42:7561-7570; 2003.
24. Jensen, S. S.; Madsen, M. W.; Lukas, J.; Bartek, J.; Binderup, L. Sensitivity to growth suppression by 1 alpha, 25-dihydroxyvitamin D(3) among MCF7 clones correlates with vitamin D receptor protein induction. J. Steroid Biochem. Mol. Biol. 811:123-133; 2002.
25. Wang, Q.; Lee, D.; Sysounthone, V.; Chandraratna, R. A. S.; Christakos, S.; Korah, R.; Wieder, R. 1,25-Dihydroxyvitamin D3 and retinoic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res. Treat. 67:157-168; 2001.
26. Colston, K. W.; Hansen, C. M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer 9:45-59; 2002.
27. Rajan, J. V.; Wang, M.; Marquis, S. T.; Chodosh, L. A. Brca 2 is coordinately regulated with Brca 1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 93:13078-13083; 1996.
28. Wartmann, M.; Cella, N.; Hofer, P.; Groner, B.; Liu, X.; Hennighausen, L.; Hynes, N. E. Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J. Biol. Chem. 271:31863-31868; 1996.
29. Liu, M.; Lee, M. H.; Cohen, M.; Bommakanti, M.; Freedman, L. P. Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Gene Dev. 10:142-153; 1996.
30. Chouvet, C.; Berger, U.; Coombes, R. 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF7, BT-20). J. Steroid Biochem. 24:373-376; 1986.
31. Eisman, J.; Sutherland, R. L.; McMenemy, M.; Fragonas, J. C.; Musgrove, E. A.; Pang, G. C. Effects of 1,25-dihydroxyvitamin D3 on cell cycle kinetics of T47D human breast cancer cells. J. Cell Physiol. 138:611-616; 1989.
32. Colston, K.; Chander, S. K.; Mackay, A. G.; Coombes, R. C. Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44:693-702; 1992.
33. Schroeder, M. D.; Brockman, J. L.; Walker, A. M.; Schuler, L. A. Inhibition of prolactin(PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D PRL. Endocrinology 144: 5300-5307; 2003.
34. Ortega, S.; Malumbres, M.; Barbacid, M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602:73-87; 2002.
35. Minella, A. C.; Swanger, J.; Bryant, E.; Welcker, M.; Hwang, H.; Clurman, B. E. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr. Biol. 12:1817-1827; 2002.
36. Harper, J. W.; Elledge, S. J.; Keyomarsi, K.; Dynlacht, B.; Tsai, L-H.; Zhang, P.; Dobrowolski, S.; Bai, C.; Connell-Crowley, L.; Swindell, E.; Fox, M. P.; Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6: 387-400; 1995.
37. Lee, J. K.; Jung, J. C.; Chun, J. S.; Bang, O. S. Expression of p21 waf1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation. Mol. Cell 13:125-129; 2002.
38. Davis, D.; Pintucci, G.; Stern, A. MAPK-dependent expression of p21 waf1 and p27 kip1 in PMA-induced differentiation of HL60 cells. FEBS Lett. 472:50-52; 2000.
39. Liu, Y.; Martindale, J. L.; Gorospe, M.; Holbrook, N. J. Regulation of p21 waf1/cip1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56:31-35; 1996.
40. Lessor, T.; Yoo, J. Y.; Davis, M.; Hamburger, A. W. Regulation of heregulin beta-1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathway. J. Cell Biochem. 70: 587-595; 1998.
41. Shibata, M. A.; Yoshidome, K.; Shibata, E.; Jorcyk, C. L.; Green, J. E. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the cdk inhibitor p21. Cancer Gene Ther. 8:23-35; 2001.
42. Katayama, M. L. H.; Pasini, F. S.; Folgueira, M. A. A. K.; Snitkovsky, I. M. L.; Brentani, M. M. Molecular targets of 1,25 (OH)2D3 in HC11 normal mouse mammary cell line. J. Steroid Biochem. Mol. Biol. 84:57-69; 2003.
43. Marcinkowska, E. Evidence that activation of MEK 1/2/ ERK1/2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res. 21:99-104; 2001.